No abstract

Abstract& The left cerebral hemisphere is dominant for language processing in most individuals. It has been suggested that this asymmetric language representation can influence behavioral performance in foveal word-naming tasks. We carried out two experiments in which we obtained laterality indices by means of functional imaging during a mental word-generation task, using functional transcranial Doppler sonography and functional magnetic resonance imaging, respectively. Subsequently, we administered a behavioral word-naming task, where participants had to name foveally presented words of different lengths shown in different fixation locations shifted horizontally across the screen. The optimal viewing position for left language dominant individuals is located between the beginning and the center of a word. It is shifted toward the end of a word for right language dominant individuals and, to a lesser extent, for individuals with bilateral language representation. These results demonstrate that interhemispheric communication is required for foveal word recognition. Consequently, asymmetric representations of language and processes of interhemispheric transfer should be taken into account in theoretical models of visual word recognition to ensure neurological plausibility. &

It is becoming increasingly clear that interhemispheric transfer is an important factor in visual word recognition. One of the two computational models of visual word recognition that includes this aspect, the SERIOL model, is tested on the basis of recently obtained behavioural word naming data. Optimal viewing position (OVP) data were collected from participants with left hemisphere language dominance, right hemisphere language dominance, and bilateral language representation (as determined by fMRI). We employ a mathematical model, which is based on some of the underlying assumptions of SERIOL, to investigate the model's ability to predict our results. We show that this mathematical model, which makes use of the original parameters, is able to perfectly predict the differences in the OVP curves observed in the three groups of participants

ZusammenfassungDie Multiple Sklerose ist eine komplexe, autoimmun vermittelte Erkrankung des zentralen Nervensystems, charakterisiert durch inflammatorische Demyelinisierung sowie axonalen/neuronalen Schaden. Die Zulassung verschiedener verlaufsmodifizierender Therapien und unser verbessertes Verständnis der Krankheitsmechanismen und -entwicklung in den letzten Jahren haben die Prognose und den Verlauf der Erkrankung deutlich verändert. Diese Aktualisierung der Behandlungsempfehlung der Multiple Sklerose Therapie Konsensus Gruppe konzentriert sich auf die wichtigsten Empfehlungen für verlaufsmodifizierende Therapien der Multiplen Sklerose im Jahr 2021. Unsere Empfehlungen basieren auf aktuellen wissenschaftlichen Erkenntnissen und gelten für diejenigen Medikamente, die in weiten Teilen Europas, insbesondere in den deutschsprachigen Ländern (Deutschland, Österreich, Schweiz), zugelassen sind.